We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+25.53%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$534B
AUM Growth
+$30.1B
Cap. Flow
-$29B
Cap. Flow %
-5.43%
Top 10 Hldgs %
18%
Holding
2,648
New
102
Increased
1,058
Reduced
979
Closed
78

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$2.63B
2
MRK icon
Merck
MRK
+$865M
3
EA
Electronic Arts
EA
+$786M
4
FRC
First Republic Bank
FRC
+$712M
5
INTU icon
Intuit
INTU
+$692M

Top Sells

Rank Stock Value
1
TTE icon
TotalEnergies
TTE
+$21.7B
2
AMZN icon
Amazon
AMZN
+$1.26B
3
NXPI icon
NXP Semiconductors
NXPI
+$1.23B
4
AET
Aetna Inc
AET
+$890M
5
GE icon
GE Aerospace
GE
+$805M

Sector Composition

Rank Sector Weight
1 Healthcare 17.33%
2 Financials 16.18%
3 Consumer Discretionary 15.26%
4 Technology 13.88%
5 Communication Services 9.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASTC icon
2526
Astrotech Corp
ASTC
$18M
$49K ﹤0.01%
248
+55
+28% +$12K
ARWR icon
2527
Arrowhead Research
ARWR
$12.2B
$47K ﹤0.01%
25,567
SUMR
2528
DELISTED
Summer Infant, Inc.
SUMR
$47K ﹤0.01%
2,722
SQBG
2529
DELISTED
Sequential Brands Group, Inc.
SQBG
$46K ﹤0.01%
293
REFR icon
2530
Research Frontiers
REFR
$15.7M
$44K ﹤0.01%
31,600
MOBL
2531
DELISTED
MobileIron, Inc.
MOBL
$44K ﹤0.01%
10,100
-49,807
-83% -$221K
STRR
2532
Star Equity Holdings
STRR
$37.8M
$43K ﹤0.01%
3,391
APVO icon
2533
Aptevo Therapeutics
APVO
$5.24M
0
GNSS icon
2534
Genasys
GNSS
$77.4M
$42K ﹤0.01%
27,759
HHS icon
2535
Harte-Hanks
HHS
$21.7M
$42K ﹤0.01%
2,975
WKHS icon
2536
Workhorse Group
WKHS
$35.2M
$42K ﹤0.01%
+5
New +$52K
CEMP
2537
DELISTED
Cempra, Inc.
CEMP
$41K ﹤0.01%
10,814
NIHD
2538
DELISTED
NII Holdings, Inc. Common Stock
NIHD
$41K ﹤0.01%
31,748
NAVB
2539
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$40K ﹤0.01%
3,500
OCC icon
2540
Optical Cable Corp
OCC
$150M
$39K ﹤0.01%
12,869
ENT
2541
DELISTED
Global Eagle Entertainment Inc.
ENT
$39K ﹤0.01%
488
RELY
2542
DELISTED
Real Industry, Inc.
RELY
$39K ﹤0.01%
+13,700
New +$67.6K
BLFS icon
2543
BioLife Solutions
BLFS
$1.73B
$32K ﹤0.01%
15,500
+3,700
+31% +$7.17K
FNJN
2544
DELISTED
Finjan Holdings, Inc.
FNJN
$28K ﹤0.01%
15,850
+400
+3% +$573
ZN
2545
DELISTED
Zion Oil & Gas, Inc.
ZN
$25K ﹤0.01%
21,100
+7,100
+51% +$9.04K
FPP
2546
DELISTED
FieldPoint Petroleum Corporation
FPP
$25K ﹤0.01%
59,200
BIOL
2547
DELISTED
Biolase, Inc.
BIOL
$24K ﹤0.01%
1
NBSE
2548
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$22K ﹤0.01%
67
ACHV icon
2549
Achieve Life Sciences
ACHV
$736M
$20K ﹤0.01%
21
CRDF icon
2550
Cardiff Oncology
CRDF
$78.6M
$20K ﹤0.01%
246

Similar funds

T. Rowe Price Associates's Q1 2017 Portfolio in Review

As of Q1 2017, T. Rowe Price Associates held 2,648 positions worth $534B, up 6% from $504B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

T. Rowe Price Associates withdrew a net $29B in Q1 2017, closing 78 positions and reducing 979 holdings. Its most notable exit was Spectra Energy Corp Wi, an estimated $404M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, T. Rowe Price Associates opened a new position in Snap worth $632M.

  • T. Rowe Price Associates's largest Q1 2017 buy was Snap: 28,319,977 shares worth $632M.
  • T. Rowe Price Associates added most to Apple in Q1 2017, an estimated $2.63B increase.
  • T. Rowe Price Associates's biggest Q1 2017 reduction was TotalEnergies, cutting an estimated $21.7B.
  • T. Rowe Price Associates fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $404M.
  • T. Rowe Price Associates's ten largest holdings make up 18% of its $534B portfolio in Q1 2017.
  • T. Rowe Price Associates opened 102 new positions and closed 78 in Q1 2017.
  • T. Rowe Price Associates's portfolio value rose 6% quarter-over-quarter to $534B.

Based on T. Rowe Price Associates's 13F filing for Q1 2017, filed 15 May 2017.